Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
SY ›
SYMZIBEL
Trademark search for:
SYMZIBEL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-02-05 — Application filed
2020-02-08 — Application filed
2020-02-08 — Application filed
2020-03-16 — Final disposition recorded
2020-03-16 — Final disposition recorded
2020-03-16 — Assigned to examiner
2020-03-16 — Final disposition recorded
2020-06-09 — Office action issued
2020-06-09 — Correspondence received in law office
2020-06-10 — Teas/email correspondence entered
2020-06-11 — Approved for pub - principal register
2020-06-24 — Notification of notice of publication e-mailed
2020-07-14 — Published for opposition
2020-07-14 — Official gazette publication confirmation e-mailed
2020-09-08 — Noa e-mailed - sou required from applicant
2021-02-10 — Sou teas extension received
2021-02-10 — Sou extension 1 filed
2021-02-10 — Sou extension 1 granted
2021-02-12 — Notice of approval of extension request e-mailed
2021-07-16 — Assigned to examiner
2021-09-07 — Sou teas extension received
2021-09-07 — Sou extension 2 filed
2021-09-07 — Sou extension 2 granted
2021-09-09 — Notice of approval of extension request e-mailed
2022-03-04 — Sou teas extension received
2022-03-04 — Sou extension 3 filed
2022-03-04 — Sou extension 3 granted
2022-03-08 — Notice of approval of extension request e-mailed
2022-07-27 — Attorney/dom.rep.revoked and/or appointed
2022-07-27 — Teas change of correspondence received
2022-07-27 — Teas revoke/app/change addr of atty/dom rep received
2022-07-27 — Teas withdrawal of attorney received-firm retains
2022-08-22 — Sou teas extension received
2022-08-22 — Sou extension 4 granted
2022-08-22 — Sou extension 4 filed
2022-08-24 — Notice of approval of extension request e-mailed
2023-04-10 — Application abandoned
2023-04-10 — Application abandoned
2023-04-10 — Final status recorded
Owner Information
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Correspondent
Sarah Anne Keefe Womble Bond Dickinson (US) LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
